Patent details

EP1141274 Title: SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING THEM FOR THERAPY

Basic Information

Publication number:
EP1141274
PCT Application Number:
PCT/US/00/00396
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009023540
PCT Publication Number:
WO/00/04071
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING THEM FOR THERAPY
French Title of Invention:
RECEPTEURS SOLUBLES BR43x2 ET PROCEDES D'UTILISATION
German Title of Invention:
LÖSLICHE REZEPTOREN BR43X2 UND VERFAHREN ZU DEREN THERAPEUTISCHEN VERWENDUNG
SPC Number:

Dates

Filing date:
07/01/2000
Grant date:
10/09/2003
EP Publication Date:
10/09/2003
PCT Publication Date:
13/07/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2001
EP B1 Publication Date:
10/09/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/01/2018
Expiration date:
07/01/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/01/2000
 
 

Name:
ZymoGenetics Inc.
Address:
1201 Eastlake Avenue East, Seattle, WA 98102, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/09/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
YEE David, P.
Address:
United States (US)

2

Name:
XU Wenfeng
Address:
United States (US)

3

Name:
MADDEN Karen
Address:
United States (US)

4

Name:
GROSS Jane, A.
Address:
United States (US)

Priority

Priority Number:
226533
Priority Date:
12/04/1994
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/11;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/12/2016
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
31/05/2018 Outgoing Correspondence 1